Curated coverage for 200-percent with top developments, timeline context, and connected threads.
A 200% pharmaceutical tariff would be economically catastrophic for American patients. Here is exactly why the supply chain cannot be reshored quickly enough to prevent it.
EuroBulletin24 Editorial Desk | Linked source
The Trump administration has signaled pharmaceutical tariffs could reach 200% by mid-to-late 2026. Here is what would happen to the price of medicines for American patients and globally.